# Cambridge Biomedical Campus > research institute located in Cambridge, England **Wikidata**: [Q5025360](https://www.wikidata.org/wiki/Q5025360) **Wikipedia**: [English](https://en.wikipedia.org/wiki/Cambridge_Biomedical_Campus) **Source**: https://4ort.xyz/entity/cambridge-biomedical-campus ## Summary Cambridge Biomedical Campus is a major research institute located in Cambridge, England, serving as one of the United Kingdom's most significant centers for biomedical research, healthcare innovation, and life sciences collaboration. The campus houses numerous research facilities, hospitals, and academic institutions, with a notable connection to AstraZeneca, the British-Swedish pharmaceutical company established in 1913. Situated on Hills Road in Cambridgeshire at coordinates 52.176°N, 0.14°E, the campus represents a concentrated ecosystem of medical research, clinical care, and commercial pharmaceutical development. ## Key Facts - **Entity Type**: Research institute, campus - **Location**: Cambridge, United Kingdom - **Street Address**: Hills Road, Cambridge - **Coordinates**: 52.176°N, 0.14°E - **Historic County**: Cambridgeshire - **Website**: https://cambridge-biomedical.com/ - **Freebase ID**: /m/026stkm - **Wikipedia Title**: Cambridge Biomedical Campus - **Commons Category**: Cambridge Biomedical Campus - **Wikipedia Languages**: commons, en, zh - **Sitelink Count**: 3 - **Related Organization**: AstraZeneca (British-Swedish pharmaceutical company, founded 1913, headquarters in UK and Sweden, employees approximately 70,600-64,600-61,000 across reporting periods, industry: pharmaceuticals) - **Country**: United Kingdom ## FAQs **What is Cambridge Biomedical Campus and what is its primary function?** Cambridge Biomedical Campus is a research institute and campus facility located in Cambridge, England, dedicated to biomedical research, healthcare innovation, and life sciences education. Its primary function is to serve as a collaborative hub bringing together academic researchers, clinical practitioners, and commercial pharmaceutical companies to advance medical science and patient care. **Which major pharmaceutical company is associated with Cambridge Biomedical Campus?** AstraZeneca, the British-Swedish pharmaceutical company founded in 1913, is closely associated with Cambridge Biomedical Campus. AstraZeneca maintains its headquarters in both the United Kingdom and Sweden and employs approximately 70,600 people, operating in the pharmaceutical industry as one of the world's largest pharmaceutical companies. **Where exactly is Cambridge Biomedical Campus located?** Cambridge Biomedical Campus is situated on Hills Road in Cambridge, Cambridgeshire, United Kingdom, at geographic coordinates 52.176°N latitude and 0.14°E longitude. The campus is positioned within the historic county of Cambridgeshire. **What languages have Wikipedia articles about Cambridge Biomedical Campus?** Wikipedia articles about Cambridge Biomedical Campus exist in three languages: English (en), Chinese (zh), and Commons (the Wikimedia Commons media repository). The campus also has a dedicated commons category for related media. **How is Cambridge Biomedical Campus categorized in knowledge bases?** In knowledge organization systems, Cambridge Biomedical Campus is classified as both a research institute and a campus. It has a Freebase identifier of /m/026stkm and a Wikidata description identifying it as a research institute located in Cambridge, England. ## Why It Matters Cambridge Biomedical Campus matters because it represents a critical concentration of biomedical expertise, research infrastructure, and commercial pharmaceutical development within a single geographic location in the United Kingdom. The campus brings together the tripartite mission of academic research, clinical healthcare delivery, and commercial pharmaceutical innovation, creating an ecosystem where scientific discoveries can progress rapidly from laboratory research to clinical application and commercial production. The significance of Cambridge Biomedical Campus extends beyond its immediate research outputs. By housing facilities connected to AstraZeneca—one of the world's largest pharmaceutical companies with a workforce exceeding 70,000 employees—the campus facilitates direct collaboration between academic researchers and commercial drug development teams. This integration accelerates the translation of basic scientific research into therapeutic treatments, medical devices, and healthcare interventions that benefit patients in the UK and globally. The campus's location in Cambridge places it within one of the world's leading university cities, leveraging the intellectual capital, talent pipeline, and research infrastructure that Cambridge University has developed over centuries. This concentration of expertise attracts further investment, talent, and collaborative opportunities, creating a virtuous cycle of innovation and development in the biomedical sciences. From a healthcare perspective, Cambridge Biomedical Campus contributes to advancing medical knowledge, developing new treatments for diseases, improving diagnostic capabilities, and training the next generation of biomedical researchers and healthcare professionals. Its work has implications for addressing some of the most pressing health challenges facing society, from chronic diseases to emerging infectious conditions. ## Notable For - **Major Research Concentration**: One of the United Kingdom's largest and most comprehensive biomedical research centers, bringing together multiple research institutions, hospitals, and commercial partners in a single campus location. - **Pharmaceutical Industry Hub**: Home to facilities and operations for AstraZeneca, one of the world's top three pharmaceutical companies, enabling direct collaboration between academic research and commercial drug development. - **Strategic Location**: Situated in Cambridge, home to one of the world's leading universities, providing access to exceptional talent, research infrastructure, and a collaborative academic environment. - **Multilingual Wikipedia Presence**: Information about the campus is available in English, Chinese, and through Wikimedia Commons, reflecting its international relevance and recognition. - **Integrated Research Ecosystem**: Combines research institute classification with campus facilities, supporting the full spectrum of biomedical research from basic science to clinical application. ## Body ### Geographic and Physical Context Cambridge Biomedical Campus is located in Cambridge, a city in Cambridgeshire, England, approximately 60 miles northeast of London. The campus occupies a prominent position on Hills Road, one of the main thoroughfares leading into Cambridge from the south. The geographic coordinates of 52.176°N latitude and 0.14°E longitude place the campus in the eastern part of England, within the Cambridge metropolitan area. The campus's location within Cambridgeshire—the historic county—places it in a region with a long history of academic excellence and innovation. Cambridge has been a center of learning since the founding of Cambridge University in 1209, and the city's reputation for scientific and technological innovation continues to attract researchers, businesses, and investment from around the world. ### Organizational Structure and Classification Cambridge Biomedical Campus is classified as both a research institute and a campus facility. This dual classification reflects its function as both a dedicated research organization and as a physical location housing multiple related entities and facilities. The research institute classification indicates that its primary purpose is the conduct of scientific research, particularly in the biomedical and life sciences fields. The campus designation suggests that the facility encompasses multiple buildings, research centers, and organizational units that share common infrastructure, administrative support, and collaborative frameworks. This campus model facilitates interdisciplinary collaboration, shared use of expensive research equipment, and the cross-pollination of ideas across different research groups and organizational units. ### Connection to AstraZeneca One of the most significant connections for Cambridge Biomedical Campus is its relationship with AstraZeneca, the British-Swedish pharmaceutical company. AstraZeneca was founded in 1913 and has grown to become one of the world's largest pharmaceutical companies, with headquarters in both the United Kingdom (Cambridge, England) and Sweden (Gothenburg). The company employs approximately 70,600 people globally, with employee figures reported at various points as 70,600, 64,600, and 61,100, reflecting the company's global workforce across different reporting periods. AstraZeneca operates in the pharmaceutical industry, focusing on the discovery, development, manufacturing, and commercialization of prescription medicines across a wide range of therapeutic areas including oncology, cardiovascular, respiratory, and immunology. The presence of AstraZeneca facilities and personnel at Cambridge Biomedical Campus creates a direct link between academic biomedical research and commercial pharmaceutical development. This connection enables the translation of basic research discoveries into potential therapeutic candidates, facilitates clinical trials, and supports the commercial production and distribution of new medicines. The collaboration between academic researchers and pharmaceutical industry professionals represents a model for accelerating medical innovation and bringing new treatments to patients more quickly. ### Digital Presence and Knowledge Representation Cambridge Biomedical Campus maintains a digital presence through its official website at https://cambridge-biomedical.com/. This website serves as the primary online interface for the campus, providing information about its facilities, research programs, organizational members, and contact information. In the landscape of digital knowledge organization, Cambridge Biomedical Campus is represented with a Freebase identifier of /m/026stkm and appears in Wikipedia with the title "Cambridge Biomedical Campus." The Wikipedia article is available in multiple languages, including English and Chinese, indicating the international interest in and relevance of the campus. Additionally, the campus has a dedicated Commons category on Wikimedia Commons, which contains media files such as photographs and diagrams related to the campus. The sitelink count of 3 indicates the number of Wikipedia language editions that contain articles about Cambridge Biomedical Campus. This relatively modest sitelink count suggests that while the campus is a significant institution within the UK biomedical research community, its international recognition may be more limited compared to some other major research institutions. ### Historical Context and Development While the source material does not provide specific dates for the founding or development of Cambridge Biomedical Campus, the campus represents the continuation of Cambridge's long tradition as a center of scientific excellence. The city's association with medical and scientific research dates back centuries, and the establishment of dedicated biomedical research facilities in the modern era represents an evolution of this tradition to meet the demands of contemporary biomedical science. The development of Cambridge Biomedical Campus as a dedicated biomedical research center reflects broader trends in research organization, including the recognition that colocation of researchers, clinical facilities, and commercial partners can accelerate innovation and improve the efficiency of the research enterprise. This model has been adopted by other major research institutions around the world, but Cambridge's particular combination of academic excellence, pharmaceutical industry presence, and government support has created a distinctive environment for biomedical research. ### Research Mission and Activities As a research institute, Cambridge Biomedical Campus is dedicated to advancing knowledge in the biomedical sciences. The specific research programs and activities conducted at the campus would typically include basic research into disease mechanisms, translational research to convert basic discoveries into clinical applications, clinical research involving patient studies and clinical trials, and development of new diagnostic methods and therapeutic interventions. The presence of multiple organizations within the campus environment facilitates interdisciplinary collaboration, where researchers from different backgrounds and organizations can work together on complex biomedical problems that require expertise from multiple fields. This collaborative approach is increasingly recognized as essential for addressing the most challenging problems in biomedical research, including complex diseases, drug resistance, and the development of personalized medicine approaches. ### Broader Impact and Significance The significance of Cambridge Biomedical Campus extends beyond its immediate research outputs to include broader impacts on the local, national, and international levels. Locally, the campus contributes to the Cambridge economy by providing employment, attracting investment, and supporting related businesses and services. The presence of a major research campus also enhances Cambridge's reputation as a center of innovation, attracting talent and businesses to the region. Nationally, Cambridge Biomedical Campus contributes to the United Kingdom's position as a world leader in biomedical research and pharmaceutical development. The collaboration between academic researchers and industry partners at the campus exemplifies the government's strategy for strengthening the UK's life sciences sector and maintaining competitiveness in the global pharmaceutical market. Internationally, the research conducted at Cambridge Biomedical Campus contributes to the global body of biomedical knowledge and has the potential to lead to new treatments and therapies that benefit patients worldwide. The campus's connection to AstraZeneca, a company with global reach and operations, ensures that research discoveries can potentially reach patients in countries around the world.